Getein Biotech, Inc (603387.SS)
CNY 8.0
(0.25%)
CNY 8.0
(0.25%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.77 Billion CNY | 2.56% |
| 2022 | 3.67 Billion CNY | 17.19% |
| 2021 | 3.13 Billion CNY | 16.22% |
| 2020 | 2.69 Billion CNY | 34.49% |
| 2019 | 2 Billion CNY | 27.84% |
| 2018 | 1.57 Billion CNY | 23.99% |
| 2017 | 1.26 Billion CNY | 191.79% |
| 2016 | 434.08 Million CNY | 32.31% |
| 2015 | 328.07 Million CNY | 58.91% |
| 2014 | 206.45 Million CNY | 33.64% |
| 2013 | 154.48 Million CNY | 72.07% |
| 2012 | 89.78 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.78 Billion CNY | 0.44% |
| 2024 Q3 | 3.93 Billion CNY | 3.02% |
| 2024 Q2 | 3.81 Billion CNY | 0.83% |
| 2023 Q1 | 3.67 Billion CNY | -0.15% |
| 2023 FY | 3.77 Billion CNY | 2.56% |
| 2023 Q3 | 3.76 Billion CNY | 2.43% |
| 2023 Q2 | 3.67 Billion CNY | 0.18% |
| 2023 Q4 | 3.77 Billion CNY | 0.1% |
| 2022 Q3 | 3.65 Billion CNY | 5.53% |
| 2022 Q2 | 3.46 Billion CNY | -2.77% |
| 2022 FY | 3.67 Billion CNY | 17.19% |
| 2022 Q1 | 3.56 Billion CNY | 13.5% |
| 2022 Q4 | 3.67 Billion CNY | 0.64% |
| 2021 Q3 | 2.72 Billion CNY | -1.03% |
| 2021 Q2 | 2.75 Billion CNY | 0.82% |
| 2021 Q1 | 2.73 Billion CNY | 1.19% |
| 2021 Q4 | 3.13 Billion CNY | 15.11% |
| 2021 FY | 3.13 Billion CNY | 16.22% |
| 2020 Q1 | 2.23 Billion CNY | 11.27% |
| 2020 Q2 | 2.2 Billion CNY | -1.48% |
| 2020 Q4 | 2.69 Billion CNY | 11.62% |
| 2020 Q3 | 2.41 Billion CNY | 9.91% |
| 2020 FY | 2.69 Billion CNY | 34.49% |
| 2019 Q2 | 1.7 Billion CNY | 1.91% |
| 2019 FY | 2 Billion CNY | 27.84% |
| 2019 Q4 | 2 Billion CNY | 16.46% |
| 2019 Q3 | 1.72 Billion CNY | 1.35% |
| 2019 Q1 | 1.66 Billion CNY | 6.28% |
| 2018 Q3 | 1.44 Billion CNY | 6.49% |
| 2018 FY | 1.57 Billion CNY | 23.99% |
| 2018 Q4 | 1.57 Billion CNY | 8.62% |
| 2018 Q2 | 1.35 Billion CNY | 1.67% |
| 2018 Q1 | 1.33 Billion CNY | 5.44% |
| 2017 Q1 | 450.75 Million CNY | 3.84% |
| 2017 Q3 | 1.17 Billion CNY | 163.67% |
| 2017 Q4 | 1.26 Billion CNY | 7.72% |
| 2017 FY | 1.26 Billion CNY | 191.79% |
| 2017 Q2 | 445.96 Million CNY | -1.06% |
| 2016 Q4 | 434.08 Million CNY | 0.0% |
| 2016 FY | 434.08 Million CNY | 32.31% |
| 2015 FY | 328.07 Million CNY | 58.91% |
| 2015 Q1 | 211.83 Million CNY | 0.0% |
| 2014 FY | 206.45 Million CNY | 33.64% |
| 2013 FY | 154.48 Million CNY | 72.07% |
| 2012 FY | 89.78 Million CNY | 0.0% |